Trial Profile
Retrospective analysis of postprogression survival in patients with hepatocellular carcinoma treated with sorafenib
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Jul 2017
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 08 Jul 2017 New trial record